Correction: Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy Classifications

Julie A. Campbell (), Glen J. Henson, Valery Fuh Ngwa, Hasnat Ahmad, Bruce V. Taylor, Ingrid Mei and Andrew J. Palmer ()
Additional contact information
Julie A. Campbell: Menzies Institute for Medical Research, University of Tasmania
Glen J. Henson: Menzies Institute for Medical Research, University of Tasmania
Valery Fuh Ngwa: Menzies Institute for Medical Research, University of Tasmania
Hasnat Ahmad: Menzies Institute for Medical Research, University of Tasmania
Bruce V. Taylor: Menzies Institute for Medical Research, University of Tasmania
Ingrid Mei: Menzies Institute for Medical Research, University of Tasmania
Andrew J. Palmer: Menzies Institute for Medical Research, University of Tasmania

PharmacoEconomics, 2025, vol. 43, issue 2, No 9, 241 pages

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40273-024-01461-0 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:43:y:2025:i:2:d:10.1007_s40273-024-01461-0

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.1007/s40273-024-01461-0

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().